Skip to search.
 FTSE 100 Up 0.26%

VIVUS Inc. (VVUS)

-NasdaqGS
2.54 Down 0.05(1.74%) 17:06 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:2.58
Open:2.57
Bid:2.52 x 12900
Ask:2.53 x 2700
1y Target Est:4.00
Beta:1.17
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:2.52 - 2.62
52wk Range:2.22 - 5.52
Volume:279,741
Avg Vol (3m):1,964,990
Market Cap:263.17m
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VVUSDown 1.74%263.17m
LLYDown 0.34%78.39b
GSKDown 0.35%109.65b
PFE 0.00%211.58b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.86
Quarterly EPS Est (Jun-15) :-0.23
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):-3.65

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback